Lisa Kalisch Ellett

Research Interests

Clinical Pharmacy and Pharmacy Practice Epidemiology Patient safety Pharmacology & Pharmacy Quality use of medicines

APrf Lisa Kalisch Ellett

Research Associate Professor of Pharmacy and Pharmacoepidemiology

School of Pharmacy and Biomedical Science

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

I am an Enterprise Fellow in Pharmacy, working in UniSA Clinical and Health Sciences.  My research focusses on identifying and resolving quality use of medicines issues in older people. From 2016-2021 I held an NHMRC-ARC Dementia Research Development fellowship, which investigated the role of medicines in causing or worsening cognitive impairment. My research interests include quality use of medicines, medication safety, dementia and pharmacoepidemiology. I am also interested in studying how pharmacists can improve the quality use of medicines and reduce medication related harm for patients.
I have supervised PhD students undertaking research investigating the role of pharmacists in the detection, prevention and treatment of delirium in elderly hospital patients; multimorbidity, polypharmacy and the identification of patients at high risk of adverse medicine events; and the prevalence and types of medication related problems experienced by people with dementia. I currently supervise PhD students investigating the role of hospital pharmacists in reducing medication related harm through participation in ward rounds, and the extent and preventability of medication related hospital admissions in people with mental health conditions.

Date Type Title Institution Name Country Amount
2025 Fellowship Fellow of the Pharmaceutical Society of Australia Pharmaceutical Society of Australia Australia -

Date Institution name Country Title
2004 University of South Australia Australia PhD
1998 University of South Australia Australia Bachelor of Pharmacy (Honours)

Year Citation
2026 Fraser, L., Wiese, M. D., Ailabouni, N., Ellett, L. K., Sirois, C., Berthelot, W., . . . Reeve, E. (2026). Patients’ attitudes towards deprescribing disease modifying anti-rheumatic drugs in rheumatoid arthritis. Patient Education and Counseling, 143(109432), 109432.
DOI
2025 Kalisch Ellett, L. M., Janetzki, J. L., Suppiah, V., Chai, W., Staff, K., Amato, D., . . . Ward, M. B. (2025). Quantifying the non-remunerated services provided by pharmacists in community pharmacies: a direct observational study. International Journal of Pharmacy Practice, online, 1-8.
DOI
2025 Cheung, E. C. L., Wang, Y., Ellett, L. K., Adesuyan, M., Szilcz, M., Shah, S., . . . Chui, C. S. L. (2025). Prescribing trends and time series analysis of blood pressure-lowering drugs among patients with dementia: a multinational database study. ECLINICALMEDICINE, 90(103595), 11 pages.
DOI
2025 Amer, H., Marotti, S., Widagdo, I., Goldsworthy, S., Johnson, J., & Kalisch Ellett, L. (2025). Collaborative pharmacist prescribing models in Australian hospitals: a scoping study. Research in Social and Administrative Pharmacy, 1-10.
DOI
2025 Dedefo, M. G., Kassie, G. M., Gebreyohannes, E. A., Lim, R., Roughead, E., & Kalisch Ellett, L. (2025). Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High-Income Countries. Pharmacology Research and Perspectives, 13(4), 9 pages.
DOI
2025 Luong, C. -H. L., Kalisch Ellett, L., Costa, J. D. O., Chidwick, K., Pratt, N., & Janetzki, J. (2025). Impact of antiretroviral shortages in HIV therapy and prevention uptake in Australia.. AIDS care, 1-11.
DOI
2025 Azroun, R., Ellett, L. K., Pratt, N., Ward, M., & Janetzki, J. (2025). National Response to Warfarin Shortages: evaluating Regulatory Substitution and Notified Shortages and Their Effects on Antithrombotic Dispensings, Pathology Monitoring and Adverse Event Trends in Australia. Drug Safety, online, 11 pages.
DOI
2025 Luong, C. H. L., Kalisch Ellett, L., Pratt, N., Staff, K., & Janetzki, J. (2025). Trends in Use of Direct-Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016-2024. Journal of Viral Hepatitis, 32(10, article no. e70082), 1-7.
DOI Europe PMC1
2025 Widagdo, I., Kerr, M., Ellett, L. K., Schlegel, C., Sadeqzadeh, E., Wang, A., . . . Pratt, N. (2025). Validity of the Updated Rx-Risk Index as a Disease Identification and Risk-Adjustment Tool for Use in Observational Health Studies. Clinical Interventions in Aging, 20, 309-323.
DOI
2025 Kalisch Ellett, L. M., Janetzki, J. L., Lim, R., Laba, T. L., & Pratt, N. L. (2025). Innovations in pharmacovigilance studies of medicines in older people. British Journal of Clinical Pharmacology, 91(1), 66-83.
DOI Scopus1 WoS2 Europe PMC2
2025 Cheung, E. C. L., Adesuyan, M., Szilcz, M., Kalisch Ellett, L. M., Shah, S., Jani, Y. H., . . . Chui, C. S. L. (2025). Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study. Age and Ageing, 54(5), 12 pages.
DOI Scopus2 WoS2 Europe PMC2
2025 Dedefo, M. G., Kassie, G. M., Gebreyohannes, E. A., Lim, R., Roughead, E., & Kalisch Ellett, L. (2025). Completeness of spontaneously reported adverse drug reactions in 4 databases. British Journal of Clinical Pharmacology, 91(12), 3389-3400.
DOI Europe PMC1
2025 Spinks, J., Mihala, G., Jennings, W., Ware, R. S., Kalisch Ellett, L. M., Roughead, E. E., & Williamson, D. (2025). Potentially preventable medication-related hospitalisations with cardiovascular disease of Aboriginal and Torres Strait Islander people, Queensland, 2013–2017: a retrospective cohort study. Medical Journal of Australia, 222(4), 198-204.
DOI
2025 Dedefo, M. G., Lim, R., Kassie, G. M., Gebreyohannes, E. A., Salekdeh, N. N., Roughead, E., & Kalisch Ellett, L. (2025). Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study. International Journal of Clinical Pharmacy, 47(2), 423-434.
DOI Scopus1 WoS1 Europe PMC1
2025 Gebreyohannes, E. A., Thornton, C., Thiessen, M., de Vries, S. T., Q Andrade, A., Kalisch Ellett, L., . . . Lim, R. (2025). Co-Designing a Consumer-Focused Digital Reporting Health Platform to Improve Adverse Medicine Event Reporting: Protocol for a Multimethod Research Project (the ReMedi Project). JMIR Research Protocols, 14, e60084-1-e60084-10.
DOI Scopus1 WoS1 Europe PMC1
2025 Marotti, S. B., Shaji, S. E., Maguire, A., Lovas-Tiong, A., Kassie, G. M., Taylor, A., . . . Kalisch Ellett, L. M. (2025). High-risk psychotropic medication use and delirium screening in older patients undergoing planned surgical procedures. Journal of Pharmacy Practice and Research, online(4), 1-8.
DOI
2025 Babu, D., Luetsch, K., Kalisch Ellett, L., Harmon, J., Marotti, S., Wisdom, A., & Rowett, D. (2025). Realist review of pharmacists' integration and participation in interprofessional ward rounds: what works, for whom, why and in what circumstances.. Research in Social and Administrative Pharmacy, 21(11), 831-841.
DOI
2025 Reeve, E., Cowan, K., Kalisch Ellett, L., Sinclair, R., Nguyen, T. A., Sluggett, J. K., & Ailabouni, N. (2025). Top 10 consumer and healthcare professional priorities for research in the field of quality use of medicines in people living with dementia. Journal of Alzheimer's Disease, 107(1), 207-222.
DOI
2025 Gutteridge, D. S., Calder, A. H., Stasinopoulos, J., Javanparast, S., Caughey, G. E., Hillen, J. B., . . . Sluggett, J. K. (2025). Quality indicators for safe and effective use of medications in long-term care settings: A systematic review. British Journal of Clinical Pharmacology, 91(11), 3054-3069.
DOI Europe PMC1
2025 Amer, H., Marotti, S., Inglis, J. M., Widagdo, I., Goldsworthy, S., Johnson, J., & Kalisch Ellett, L. (2025). Evaluating medication discrepancies and harm: a matched cohort study of collaborative pharmacist prescribing in a statewide healthcare system using electronic prescribing. International Journal of Clinical Pharmacy, online, 1-10.
DOI Scopus1 Europe PMC1
2025 Fraser, L., Ailabouni, N., Ellett, L. K., Tan, J. M., Freeman, A., Proudman, S. M., . . . Wiese, M. D. (2025). A scoping review of disease-modifying antirheumatic drug nonadherence in rheumatoid arthritis: Measurement, prevalence and implications for clinical practice. British Journal of Clinical Pharmacology, online(12), 1-11.
DOI Europe PMC1
2025 Janetzki, J., Johnson, J., Kalisch Ellett, L., Ho, J. N., Hall, K., Ward, M., & Pratt, N. (2025). Effect and illustrative costs of downscheduling on government subsidised dispensings of triptans in Australia: a 10-year analysis. Australian Health Review, 49(4, article no. AH25050), 1-7.
DOI
2025 Janetzki, J., Kalisch, L., Hall, K., & Pratt, N. (2025). Utilisation trends of lisdexamfetamine: insights from recent medicine shortages in Australia. Pharmacoepidemiology and Drug Safety, 34(2, article no. e70113), 1-6.
DOI Scopus1 WoS1 Europe PMC1
2024 Babu, D., Marotti, S., Rowett, D., Lim, R., Wisdom, A., & Kalisch Ellett, L. (2024). What is impacting clinical pharmacists' participation in an interprofessional ward round: a thematic analysis of a national survey. Journal of Interprofessional Care, 38(3), 444-452.
DOI Scopus4 WoS5 Europe PMC1
2024 Babu, D., Rowett, D., Kalisch Ellett, L., Marotti, S., Wisdom, A., Lim, R., & Harmon, J. (2024). Exploration of 'micro' level factors that affect the involvement of clinical pharmacists in interprofessional ward rounds in hospitals: through the lens of social cognitive theory. Research in Social and Administrative Pharmacy, 20(7), 654-664.
DOI Scopus4 WoS3 Europe PMC3
2024 Dedefo, M. G., Lim, R., Kassie, G. M., Roughead, E., & Ellett, L. K. (2024). Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey. European Journal of Clinical Pharmacology, 80(10), 1543-1554.
DOI Scopus5 WoS5 Europe PMC5
2023 Reeve, E., Chenoweth, L., Sawan, M., Nguyen, T. A., Kalisch Ellett, L., Gilmartin-Thomas, J., . . . Hilmer, S. N. (2023). Consumer and Healthcare Professional Led Priority Setting for Quality Use of Medicines in People with Dementia: Gathering Unanswered Research Questions. Journal of Alzheimer S Disease, 91(3), 933-960.
DOI Scopus6 WoS5 Europe PMC4
2023 Lim, R., Dumuid, D., Parfitt, G., Stanford, T., Post, D., Bilton, R., . . . Roughead, E. E. (2023). Using wrist-worn accelerometers to identify the impact of medicines with anticholinergic or sedative properties on sedentary time: A 12-month prospective analysis. Maturitas, 172, 9-14.
DOI Scopus7 WoS7 Europe PMC5
2023 Kalisch Ellett, L. M., Dorj, G., Andrade, A. Q., Bilton, R. L., Rowett, D., Whitehouse, J., . . . Roughead, E. E. (2023). Prevalence and preventability of adverse medicine events in a sample of Australian aged-care residents: a secondary analysis of data from the ReMInDAR trial. Drug Safety, 46(5), 493-500.
DOI Scopus4 WoS3 Europe PMC3
2023 Dorj, G., Nair, N. P., Bereznicki, L., Kelly, T. L., Pratt, N., Kalisch-Ellett, L., . . . Roughead, E. (2023). Correction to: Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial (Drugs & Aging, (2023), 40, 1, (49-58), 10.1007/s40266-022-00983-6). Drugs and Aging, 40(1), 89.
DOI
2023 Dorj, G., Nair, N. P., Bereznicki, L., Thu Kelly, L., Pratt, N., Kalisch Ellet, L., . . . Roughead, E. (2023). Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial. Drugs & Aging, 40(1), 49-58.
DOI Scopus7 WoS8 Europe PMC5
2023 Andrade, A. Q., Calabretto, J. -P., Pratt, N., Kalisch-Ellett, L., LeBlanc, V. T., & Roughead, E. E. (2023). Precision public health intervention for care coordination: A real world study. British Journal of General Practice, 73(728), e220-1-e220-11.
DOI Scopus1 Europe PMC1
2023 Babu, D., Rowett, D., Lim, R., Marotti, S., Wisdom, A., & Kalisch Ellett, L. (2023). Clinical pharmacists' participation in ward rounds in hospitals: responses from a national survey. International Journal Of Pharmacy Practice, 31(4), 409-416.
DOI Scopus7 WoS8 Europe PMC5
2022 Andrade, A. Q., Calabretto, J. -P., Pratt, N. L., Kalisch-Ellett, L. M., Kassie, G. M., LeBlanc, V. T., . . . Roughead, E. E. (2022). Implementation and Evaluation of a Digitally Enabled Precision Public Health Intervention to Reduce Inappropriate Gabapentinoid Prescription: Cluster Randomized Controlled Trial. Journal of Medical Internet Research, 24(1), e33873-1-e33873-12.
DOI Scopus5 WoS6 Europe PMC6
2022 Roughead, E. E., Pratt, N. L., Parfitt, G., Rowett, D., Kalisch-Ellett, L. M., Bereznicki, L., . . . Lim, R. (2022). Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial). AGE AND AGEING, 51(4), 1-9.
DOI Scopus24 WoS21 Europe PMC25
2022 Cuthbert, A. R., Giles, L. C., Glonek, G., Ellett, L. M. K., & Pratt, N. L. (2022). A comparison of survival models for prediction of eight-year revision risk following total knee and hip arthroplasty. BMC Medical Research Methodology, 22(1), 164-1-164-13.
DOI Scopus9 WoS8 Europe PMC6
2022 Roughead, E. E., Ramsay, E. N., Kalisch Ellett, L. M., Khoo, A., Moffatt, A., & Pratt, N. L. (2022). Variation in health service use by veterans with an accepted disability of post-traumatic stress disorder who had a service record post 1975: A cluster analysis. BMJ Military Health, 168(1), 76-81.
DOI Scopus1 WoS1
2022 Lim, R., Kelly, T. L., Andrade, A. Q., Kalisch Ellett, L. M., Bilton, R., Dorj, G., . . . Roughead, E. E. (2022). Frailty trajectory over one year among residential aged care (nursing home) residents. Frontiers In Medicine, 9(1010444), 1-8.
DOI Scopus4 WoS4 Europe PMC4
2022 Dorj, G., Lim, R., Ellett, L. K., Kelly, T. L., Andrade, A., Widagdo, I., . . . Roughead, E. (2022). Medicine-related problems: a recurrent issue among residents living in nursing homes. Frontiers In Pharmacology, 13, 1-9.
DOI Scopus1 WoS2 Europe PMC1
2022 Hillen, J., Ward, M., Slee, M., Stanford, T., Roughead, E., Kalisch Ellett, L., & Pratt, N. (2022). Utilisation of disease modifying treatment and diversity of treatment pathways in relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders, 57(article no. 103412), 8 pages.
DOI Scopus3 WoS3 Europe PMC3
2022 Hillen, J. B., Stanford, T., Ward, M., Roughead, E. E., Kalisch-Ellett, L., & Pratt, N. (2022). Rituximab and Pyoderma Gangrenosum: An Investigation of Disproportionality Using a Systems Biology-Informed Approach in the FAERS Database. Drugs Real World Outcomes, 9(4), 639-647.
DOI Scopus3 WoS2 Europe PMC3
2022 Kassie, G. M., Roughead, E. E., Nguyen, T. A., Pratt, N. L., & Kalisch Ellett, L. M. (2022). The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study. Drug Safety, 45(1), 75-82.
DOI Scopus10 WoS10 Europe PMC10
2022 Lim, R., Thornton, C., Stanek, J., Ellett, L. K., & Thiessen, M. (2022). Development of a Web-Based System to Report Medication-Related Adverse Effects: Design and Usability Study. Jmir Formative Research, 6(10), 10 pages.
DOI Scopus6 WoS5 Europe PMC4
2022 Lim, R., Ellett, L. M. K., Semple, S., & Roughead, E. E. (2022). The extent of medication-related hospital admissions in Australia: a review from 1988 to 2021. Drug Safety, 45(3), 249-257.
DOI Scopus78 WoS73 Europe PMC58
2021 Lim, R., Kalisch Ellett, L., Roughead, E. E., Cheah, P. Y., & Masnoon, N. (2021). Patient-reported questionnaires to identify adverse drug reactions: a systematic review. International Journal of Environmental Research and Public Health, 18(22, article no. 11877), 1-17.
DOI Scopus17 WoS17 Europe PMC16
2021 Ailabouni, N. J., Hilmer, S. N., Kalisch, L., Braund, R., & Reeve, E. (2021). COVID-19 pandemic: considerations for safe medication use in older adults with multimorbidity and polypharmacy. The journals of gerontology. Series A, Biological sciences and medical sciences, 76(6), 1068-1073.
DOI Scopus17 WoS15 Europe PMC18
2021 Pratt, N. L., Ellett, L. M. K., Andrade, A. Q., Le Blanc, V. T., Barratt, J., & Roughead, E. E. (2021). Prevalence of multiple risk factors for poor outcomes associated with COVID-19 among an elderly Australian population. Australian Journal of General Practice, 50(1-2), 84-89.
DOI Scopus4 WoS3 Europe PMC3
2021 Kalisch Ellett, L. M., Kassie, G. M., Caughey, G. E., Pratt, N. L., Ramsay, E. N., & Roughead, E. E. (2021). Medication-related hospital admissions in aged care residents. Australasian journal on ageing, 40(4), e323-e331.
DOI Scopus10 WoS10 Europe PMC10
2021 Lee, H. J., Roughead, E. E., Han, E., Lee, J., & Kalisch Ellett, L. (2021). Post-market utilization patterns of Alzheimer’s disease treatments in South Korea: comparison with countries with universal health coverage. European Journal of Clinical Pharmacology, 77(6), 921-929.
DOI Scopus5 WoS5 Europe PMC5
2021 Lim, R., Moffat, A. K., Young, R., & Kalisch Ellett, L. M. (2021). Use of medicines in adults with autism spectrum disorder in Australia. Journal of Pharmacy Practice and Research, 51(5), 410-414.
DOI Scopus2 WoS1
2021 Pearson, S. A., Pratt, N., Costa, J. D. O., Zoega, H., Laba, T. L., Etherton-Beer, C., . . . Henry, D. (2021). Generating real-world evidence on the quality use, benefits and safety of medicines in australia: History, challenges and a roadmap for the future. International Journal of Environmental Research and Public Health, 18(24), 20 pages.
DOI Scopus18 WoS15 Europe PMC13
2021 Kalisch Ellett, L. M., Kassie, G. M., Ramsay, E. N., Pratt, N. L., & Roughead, E. E. (2021). Evaluation of Renal Function Testing in Older Australian Veterans Dispensed Medicines that Require Renal Function Monitoring. Drugs and Aging, 38(11), 995-1002.
DOI Scopus1 WoS1 Europe PMC1
2021 Ghezzi, E., Chan, M., Kalisch Ellett, L. M., Ross, T. J., Richardson, K., Ho, J. N., . . . Keage, H. A. D. (2021). The effects of anticholinergic medications on cognition in children: a systematic review and meta-analysis. Scientific Reports, 11(1), 15 pages.
DOI Scopus13 WoS12 Europe PMC9
2020 Moffat, A. K., Pratt, N. L., Ellett, L. M. K., Ramsay, E. N., & Roughead, E. E. (2020). Comorbidities in an Australian sample of chronic and new opioid users. Journal of Opioid Management, 16(2), 103-110.
DOI Scopus1 Europe PMC1
2020 Masnoon, N., Shakib, S., Kalisch Ellett, L., & Caughey, G. E. (2020). Rationalisation of polypharmacy in practice: a survey of physicians and pharmacists. Journal of Pharmacy Practice and Research, 50(3), 233-241.
DOI Scopus5
2020 Masnoon, N., Shakib, S., Kalisch Ellett, L., & Caughey, G. E. (2020). Predictors of unplanned hospitalisation in the older population: The role of polypharmacy and other medication and chronic disease-related factors. Australasian Journal on Ageing, 39(3), 436-446.
DOI Scopus4 WoS4 Europe PMC3
2020 Lim, R., Bereznicki, L., Corlis, M., Kalisch Ellett, L. M., Kang, A. C., Merlin, T., . . . Roughead, E. E. (2020). Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome.. BMJ Open, 10(4), e032851.
DOI Scopus12 WoS12 Europe PMC11
2020 Masnoon, N., Kalisch Ellett, L., Shakib, S., & Caughey, G. E. (2020). Predictors of Mortality in the Older Population: The Role of Polypharmacy and Other Medication and Chronic Disease-Related Factors. Drugs and Aging, 37(10), 767-776.
DOI Scopus16 WoS15 Europe PMC13
2020 Moffat, A. K., Westaway, K. P., Apajee, J., Frank, O., Shute, R., Weston, C., . . . Roughead, E. E. (2020). Impact of a patient-specific national programme aimed at increasing the use of emollient moisturisers to reduce the risk of skin tears: a longitudinal cohort study.. BMJ open, 10(10), e039579.
DOI WoS1 Europe PMC1
2020 Kalisch Ellett, L. M., & Lim, R. (2020). We need to do better: Most people with dementia living in aged care facilities use antipsychotics for too long, for off-label indications and without documented consent. International Psychogeriatrics, 32(3), 299-302.
DOI Scopus7 WoS5 Europe PMC5
2020 Moffat, A. K., Pratt, N. L., Kerr, M., Ellett, L. M. K., & Roughead, E. E. (2020). Risk of chronic opioid use in older persons with pre-existing anxiety. Journal of Opioid Management, 16(1), 59-66.
DOI Scopus3 Europe PMC3
2020 Kalisch Ellett, L. M., Pratt, N. L., Nguyen, T. A., & Roughead, E. E. (2020). Use of health and support services by people living with dementia in the community setting. Australasian Journal on Ageing, 39(4), 341-349.
DOI Scopus4 WoS5 Europe PMC2
2020 King, C. E., Pratt, N. L., Craig, N., Thai, L., Wilson, M., Nandapalan, N., . . . Behm, E. C. (2020). Detecting medicine safety signals using prescription sequence symmetry analysis of a National Prescribing Data Set. Drug Safety, 43(8), 787-795.
DOI Scopus13 WoS14 Europe PMC13
2020 Andrade, A. Q., LeBlanc, V. T., Kalisch Ellett, L. M., Pratt, N. L., Moffat, A., Blacker, N., . . . Roughead, E. E. (2020). Determinants of usefulness in professional behaviour change interventions: observational study of a 15-year national program. BMJ open, 10(10), 1-8.
DOI Scopus3 WoS4 Europe PMC3
2020 Kalisch Ellett, L. M., Kemp-Casey, A., Kassie, G. M., Pratt, N. L., & Roughead, E. E. (2020). Use of analgesics following rescheduling of codeine in Australia: An interrupted time series analysis in the veteran population. International Journal of Drug Policy, 81, 7 pages.
DOI Scopus7 WoS7 Europe PMC4
2020 Baek, Y. H., Lee, H., Kim, W. J., Chung, J. E., Pratt, N., Kalisch Ellett, L., & Shin, J. Y. (2020). Uncertain Association Between Benzodiazepine Use and the Risk of Dementia: A Cohort Study. Journal of the American Medical Directors Association, 21(2), 201-211.e2.
DOI Scopus26 WoS26 Europe PMC19
2020 Eshetie, T. C., Roberts, G., Nguyen, T. A., Gillam, M. H., Maher, D., & Kalisch Ellett, L. M. (2020). Potentially inappropriate medication use and related hospital admissions in aged care residents: The impact of dementia. British Journal of Clinical Pharmacology, 86(12), 2414-2423.
DOI Scopus9 WoS8 Europe PMC8
2020 Parfitt, G., Post, D., Ellett, L. K., Lim, R., Penington, A., Corlis, M., & Roughead, E. (2020). A cross-sectional assessment of the relationship between sedative medication and anticholinergic medication use and the movement behaviour of older adults living in residential aged care. Peerj, 8(e9605), 9 pages.
DOI Scopus2 WoS2 Europe PMC2
2019 Eshetie, T. C., Nguyen, T. A., Gillam, M. H., & Kalisch Ellett, L. M. (2019). Potentially inappropriate prescribing before and after initiation of medicines for dementia: An Australian population-based study. Geriatrics and Gerontology International, 19(7), 654-659.
DOI Scopus5 WoS5 Europe PMC3
2019 Spinks, J. M., Kalisch Ellett, L. M., Spurling, G., Theodoros, T., Williamson, D., & Wheeler, A. J. (2019). Adaptation of potentially preventable medication-related hospitalisation indicators for indigenous populations in Australia using a modified Delphi technique. BMJ Open, 9(11), 12 pages.
DOI Scopus7 WoS7 Europe PMC5
2019 Kassie, G. M., Kalisch Ellett, L. M., Nguyen, T. A., & Roughead, E. E. (2019). Use of medicines that may precipitate delirium prior to hospitalisation in older Australians with delirium: An observational study. Australasian Journal on Ageing, 38(2), 124-131.
DOI Scopus11 WoS10 Europe PMC10
2019 Eshetie, T. C., Nguyen, T. A., Gillam, M. H., & Kalisch Ellett, L. M. (2019). Medication Use for Comorbidities in People with Alzheimer's Disease: An Australian Population-Based Study. Pharmacotherapy, 39(12), 1146-1156.
DOI Scopus16 WoS16 Europe PMC15
2019 Nguyen, T. A., Gilmartin Thomas, J., Tan, E. C. K., Kalisch Ellett, L., Eshetie, T., Gillam, M., & Reeve, E. (2019). The impact of pharmacist interventions on quality use of medicines, quality of life, and health outcomes in people with dementia and/or cognitive impairment: a systematic review. Journal of Alzheimer's disease, 71(1), 83-96.
DOI Scopus27 WoS25 Europe PMC21
2019 Nguyen, T. A., Gilmartin Thomas, J., Tan, E. C. K., Ellett, L. K., Eshetie, T., Gillam, M., & Reeve, E. (2019). P3‐502: The impact of pharmacist interventions on quality use of medicines, quality of life and health outcomes in people with dementia and cognitive impairment: a systematic review.. Alzheimer S & Dementia, 15(7S), 501.
DOI
2019 Kalisch Ellett, L. M., Moffat, A. K., Gadzhanova, S., Pratt, N. L., Apajee, J., Woodward, M., & Roughead, E. E. (Eds.) (2019). Reduction in use of risperidone for dementia in Australia following changed guidelines. Pharmacy, 7(3), 1-11.
2019 Lim, R., Kalisch Ellett, L. M., Widagdo, I. S., Pratt, N. L., & Roughead, E. E. (2019). Analysis of anticholinergic and sedative medicine effects on physical function, cognitive function, appetite and frailty: A cross-sectional study in Australia. BMJ Open, 9(9), 9 pages.
DOI Scopus33 WoS31 Europe PMC25
2019 Ellett, L. M. K., Kassie, G. M., Pratt, N. L., Kerr, M., & Roughead, E. E. (2019). Prevalence and Duration of Use of Medicines Recommended for Short-Term Use in Aged Care Facility Residents. PHARMACY, 7(2), 11 pages.
DOI WoS7 Europe PMC7
2019 Kalisch Ellett, L. M., Pratt, N. L., Apajee, J., & Roughead, E. E. (2019). Initiation and continuation of antipsychotic medicines in older people following non-psychiatric hospital admission. International Journal of Clinical Pharmacy, 41(5), 1341-1347.
DOI Scopus6 WoS6 Europe PMC3
2019 Eshetie, T. C., Nguyen, T. A., Gillam, M. H., & Kalisch Ellett, L. M. (2019). Potentially inappropriate prescribing in people with dementia: An Australian population-based study. International Journal of Geriatric Psychiatry, 34(10), 1498-1505.
DOI Scopus16 WoS14 Europe PMC13
2019 Caughey, G. E., Hillen, J. B., Bacon, S., Bullock, N., Bullock, V., & Kalisch-Ellett, L. M. (2019). Implementation of medication-related potentially preventable hospitalisation indicators in a chronic disease management program for multimorbidity.. International Journal for Quality in Health Care, 31(2), 133-139.
DOI Scopus2 WoS2 Europe PMC2
2019 Pratt, N. L., Ramsay, E., Kalisch Ellett, L. M., Duszynski, K., Shakib, S., Kerr, M., . . . Roughead, E. E. (2019). Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study. BMJ Open, 9(5), e026486.
DOI Scopus9 WoS9 Europe PMC7
2019 Ellett, L. M. K., Moffat, A. K., Gadzhanova, S., Pratt, N. L., Apajee, J., Woodward, M., & Roughead, E. E. (2019). Reduction in Use of Risperidone for Dementia in Australia Following Changed Guidelines. PHARMACY, 7(3), 11 pages.
DOI WoS6 Europe PMC7
2018 Ramsay, E., Pratt, N., Moffat, A., Kalisch Ellett, L., & Roughead, E. (2018). Evaluating the assumptions of the self-controlled case series design in studies investigating the risks of antipsychotic use in the older population. Pharmacoepidemiology and drug safety, 27(S2, article no. 776), 354-355.
DOI
2018 Pratt, N., Kerr, M., Barratt, J., Kemp Casey, A., Kalisch Ellett, L., Ramsay, E., & Roughead, E. (2018). The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System. BMJ open, 8(4), 1-8.
DOI Scopus227 WoS228 Europe PMC195
2018 Kalisch Ellett, L. M., Pratt, N. L., Kerr, M., & Roughead, E. E. (2018). Antipsychotic polypharmacy in older Australians. International Psychogeriatrics, 30(4), 539-546.
DOI Scopus8 WoS9 Europe PMC6
2018 Kassie, G. M., Nguyen, T. A., Kalisch Ellett, L. M., Pratt, N. L., & Roughead, E. E. (2018). Do risk prediction models for postoperative delirium consider patients' preoperative medication use?. Drugs and aging, 35(3), 213-222.
DOI Scopus12 WoS12 Europe PMC10
2018 Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. (2018). Tools for Assessment of the Appropriateness of Prescribing and Association with Patient-Related Outcomes: A Systematic Review. Drugs and Aging, 35(1), 43-60.
DOI Scopus51 WoS49 Europe PMC43
2018 Nguyen, T. A., Pham, T., Vu, H. T. T., Nguyen, T. X., Vu, T. T., Nguyen, B. T. T., . . . Roughead, E. E. (2018). Use of potentially inappropriate medications in people with dementia in Vietnam and its associated factors. American Journal of Alzheimer's Disease and other Dementias, 33(7), 423-432.
DOI Scopus17 WoS14 Europe PMC11
2018 Kalisch Ellett, L. M., Lim, R., Pratt, N. L., Kerr, M., Ramsay, E. N., Leblanc, T. V., . . . Roughead, E. E. (2018). Reducing hypnotic use in insomnia management among Australian veterans: Results from repeated national interventions. BMC Health Services Research, 18(1), 626.
DOI Scopus4 WoS4 Europe PMC4
2018 Kalisch Ellett, L. M., Pratt, N. L., Sluggett, J. K., Ramsay, E. N., Kerr, M., LeBlanc, V. T., . . . Roughead, E. E. (2018). Sustaining practice change in health care: the impact of a national quality improvement program on the uptake of collaborative medicines reviews. Journal of pharmacy practice and research, 48(3), 222-230.
DOI Scopus7
2018 Park, S. K., Baek, Y. H., Pratt, N., Kalisch Ellett, L., & Shin, J. Y. (2018). The uncertainty of the association between proton pump inhibitor use and the risk of dementia: prescription sequence symmetry analysis using a Korean healthcare database between 2002 and 2013. Drug safety, 41(6), 615-624.
DOI Scopus28 WoS23 Europe PMC23
2018 Kalisch Ellett, L., Pratt, N., & Roughead, E. (2018). Analgesic use in Vietnam veterans' with musculoskeletal pain. Journal of military and veterans' health, 26(3), 28-35.
WoS1
2018 Eshetie, T. C., Nguyen, T. A., Gillam, M. H., & Kalisch Ellett, L. M. (2018). A narrative review of problems with medicines use in people with dementia. Expert Opinion on Drug Safety, 17(8), 825-836.
DOI Scopus26 WoS24 Europe PMC20
2018 Kassie, G. M., Kalisch Ellett, L. M., Nguyen, T. A., & Roughead, E. E. (2018). Knowledge of Australian hospital pharmacists regarding delirium in elderly patients. Journal of Pharmacy Practice and Research, 48(2), 116-123.
DOI Scopus3
2017 Kassie, G. M., Kalisch Ellett, L. M., Nguyen, T. A., & Roughead, E. E. (2017). Current practice and opinions of hospital pharmacists regarding their role in the screening, prevention and treatment of delirium. International Journal of Clinical Pharmacy, 39(6), 1194-1200.
DOI Scopus7 WoS7 Europe PMC5
2017 Caughey, G., Kalisch Ellett, L., Barratt, J., & Shakib, S. (2017). Apixaban, concomitant medicines and spontaneous reports of haemorrhagic events. Therapeutic Advances in Drug Safety, 8(5), 157-164.
DOI Scopus8 WoS7 Europe PMC5
2017 Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatrics, 17(1), 1-10.
DOI Scopus2285 WoS2149 Europe PMC1718
2017 Kalisch Ellett, L. M., Pratt, N. L., Sluggett, J. K., Ramsay, E. N., Kerr, M., LeBlanc, V. T., . . . Roughead, E. E. (2017). Patient-specific prescriber feedback can increase the rate of osteoporosis screening and treatment: results from two national interventions. Archives of osteoporosis, 12(1, article no. 17), 1-7.
DOI Scopus6 WoS6 Europe PMC5
2017 Roughead, E. E., Pratt, N. L., Kalisch Ellett, L. M., Ramsay, E. N., Barratt, J. D., Morris, P., & Killer, G. (2017). Posttraumatic Stress Disorder, Antipsychotic Use and Risk of Dementia in Veterans. Journal of the American Geriatrics Society, 65(7), 1521-1526.
DOI Scopus20 WoS20 Europe PMC17
2017 Pratt, N. L., Kalisch Ellett, L. M., Sluggett, J. K., Gadzhanova, S. V., Ramsay, E. N., Kerr, M., . . . Roughead, E. E. (2017). Use of proton pump inhibitors among older Australians: National quality improvement programmes have led to sustained practice change. International Journal for Quality in Health Care, 29(1), 75-82.
DOI Scopus27 WoS21 Europe PMC22
2017 Kassie, G. M., Nguyen, T. A., Kalisch Ellett, L. M., Pratt, N. L., & Roughead, E. E. (2017). Preoperative medication use and postoperative delirium: a systematic review. BMC geriatrics, 17(article no. 298), 1-10.
DOI Scopus99 WoS85 Europe PMC72
2016 Kalisch Ellett, L. M., Pratt, N. L., Le, B. V. T., Westaway, K., & Roughead, E. E. (2016). Increased risk of hospital admission for dehydration or heat-related illness after initiation of medicines: a sequence symmetry analysis. Journal of clinical pharmacy and therapeutics, 41(5), 503-507.
DOI Scopus34 WoS25 Europe PMC26
2016 Wahab, I. A., Pratt, N. L., Ellett, L. K., & Roughead, E. E. (2016). Sequence symmetry analysis as a signal detection tool for potential heart failure adverse events in an administrative claims database. Drug Safety, 39(4), 347-354.
DOI Scopus20 WoS19 Europe PMC15
2016 Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Sluggett, J. K., Barratt, J. D., & Roughead, E. E. (2016). Central Nervous System-Acting Medicines and Risk of Hospital Admission for Confusion, Delirium, or Dementia. Journal of the American Medical Directors Association, 17(6), 530-534.
DOI Scopus9 WoS9 Europe PMC7
2015 Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Barratt, J. D., & Roughead, E. E. (2015). Response to lertxundi and colleagues. Journal of the American geriatrics society, 63(5), 1054-1055.
DOI
2015 Pratt, N. L., Kalisch Ellett, L. M., Sluggett, J. K., Ramsay, E. N., Kerr, M., LeBlanc, V. T., . . . Roughead, E. E. (2015). Commitment questions targeting patients promotes uptake of under-used health services: findings from a national quality improvement program in Australia. Social Science and Medicine, 145, 1-6.
DOI Scopus6 WoS6 Europe PMC6
2015 Pratt, N. L., Ramsay, E. N., Kalisch Ellett, L. M., Nguyen, T. A., & Roughead, E. E. (2015). Association between ophthalmic timolol and hospitalisation for bradycardia. Journal of ophthalmology, 2015(article no. 567387), 1-6.
DOI Scopus18 WoS14 Europe PMC11
2015 Caughey, G., Kalisch Ellett, L., Goldstein, S., & Roughead, E. (2015). Suboptimal medication-related quality of care preceding hospitalisation of older patients. Medical Journal of Australia, 203(5), 220.e1-220.e7.
DOI Scopus6 WoS6 Europe PMC6
2015 Mcdonald, C., Kalisch Ellett, L., Barratt, J., & Caughey, G. (2015). An international comparison of spontaneous adverse event reports and potentially inappropriate medicine use associated with dabigatran. Pharmacoepidemiology and Drug Safety, 24(4), 399-405.
DOI Scopus23 WoS21 Europe PMC20
2014 Caughey, G., Kalisch Ellett, L., & Wong, T. (2014). Development of evidence-based Australian medication-related indicators of potentially preventable hospitalisations: a modified RAND appropriateness method. BMJ Open, 4(4), e004625-1-e004625-17.
DOI Scopus26 WoS24 Europe PMC19
2014 McDonald, C., Kalisch Ellett, L., Barratt, J., & Caughey, G. (2014). A cross-country comparison of rivaroxaban spontaneous adverse event reports and concomitant medicine use with the potential to increase the risk of harm. Drug Safety, 37(12), 1029-1035.
DOI Scopus16 WoS15 Europe PMC13
2014 Pratt, N., Ramsay, E., Kemp, A., Kalisch-Ellett, L., Shakib, S., Caughey, G., . . . Roughead, E. (2014). Ranibizumab and risk of hospitalisation for ischaemic stroke and myocardial infarction in patients with age-related macular degeneration: a self-controlled case-series analysis. Drug Safety, 37(12), 1021-1027.
DOI Scopus17 WoS13 Europe PMC14
2014 Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Barratt, J. D., & Roughead, E. E. (2014). Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia. Journal of the American Geriatric Society, 62(10), 1916-1922.
DOI Scopus105 WoS88 Europe PMC77
2014 Pratt, N. L., Ramsay, E. N., Kalisch Ellett, L. M., Nguyen, T. A., Barratt, J. D., & Roughead, E. E. (2014). Association between use of multiple psychoactive medicines and hospitalization for falls : retrospective analysis of a large healthcare claim database. Drug safety, 37(7), 529-535.
DOI Scopus35 WoS33 Europe PMC28
2014 Kalisch Ellett, L. M., Pratt, N. L., Barratt, J. D., Rowett, D., & Roughead, E. E. (2014). Risk of medication-associated initiation of oxybutynin in elderly men and women. Journal of the American Geriatrics Society, 62(4), 690-695.
DOI Scopus22 WoS20 Europe PMC16
2014 Wahab, I. A., Pratt, N. L., Kalisch, L. M., & Roughead, E. E. (2014). Comparing time to adverse drug reaction signals in a spontaneous reporting database and a claims database : a case study of rofecoxib-induced myocardial infarction and rosiglitazone-induced heart failure signals in Australia. Drug safety, 37(1), 53-64.
DOI Scopus33 WoS32 Europe PMC24
2013 Wahab, I. A., Pratt, N. L., Wiese, M. D., Kalisch, L. M., & Roughead, E. E. (2013). The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection. Pharmacoepidemiology and drug safety, 22(5), 496-502.
DOI Scopus69 WoS62 Europe PMC59
2013 Roughead, E., Kalisch Ellett, L., Ramsay, E., Pratt, N., Barratt, J., LeBlanc, V., . . . Gilbert, A. (2013). Bridging evidence-practice gaps: improving use of medicines in elderly Australian veterans. BMC Health Services Research, 13(article no. 514), 1-14.
DOI Scopus29 WoS28 Europe PMC25
2013 Kalisch Ellett, L. M., Pratt, N. L., Barratt, J. D., & Roughead, E. E. (2013). Urinary incontinence: a poorly recognised adverse effect of medicines. Pharmacoepidemiology and drug safety, 22(s1, article no. 948), 475.
2013 Wahab, I. A., Pratt, N. L., Kalisch Ellett, L. M., & Roughead, E. E. (2013). The detection of adverse events in randomized clinical trials : can we really say new medicines are safe?. Current drug safety, 8(2), 104-113.
DOI Scopus13 WoS13 Europe PMC11
2013 Kalisch Ellett, L. M., Ramsay, E. N., Barratt, J. D., Gilbert, A. L., & Roughead, E. E. (2013). Home medicines reviews: extent of uptake by high-risk veterans. Journal of pharmacy practice and research, 43(3), 182-186.
DOI Scopus9
2013 Wahab, I. A., Pratt, N. L., Kalisch Ellett, L. M., & Roughead, E. E. (2013). Sequence symmetry analysis and disproportionality analyses: what percentage of adverse drug reaction do they signal?. Advances in pharmacoepidemiology & drug safety, 2(4), 1-5.
DOI
2012 Kalisch, L., Caughey, G., Barratt, J., Ramsay, E., Killer, G., Gilbert, A., & Roughead, E. (2012). Prevalence of preventable medication-related hospitalizations in Australia: An opportunity to reduce harm. International Journal for Quality in Health Care, 24(3), 239-249.
DOI Scopus63 WoS53 Europe PMC46
2012 Roughead, E. E., Kalisch Ellett, L. M., Pratt, N. L., Killer, G., Barnard, A., & Gilbert, A. L. (2012). Managing glaucoma in those with co-morbidity : not as easy as it seems. Ophthalmic Epidemiology, 19(2), 74-82.
DOI Scopus33 WoS26 Europe PMC22
2011 Roughead, E., Kalisch, L., Ramsay, E., Ryan, P., & Gilbert, A. (2011). Continuity of care: when do patients visit community health care providers after leaving hospital?. Internal Medicine Journal, 41(9), 662-667.
DOI Scopus37 WoS38 Europe PMC29
2011 Bell, J. S., Kalisch Ellett, L. M., Ramsay, E. N., Pratt, N. L., Barratt, J. D., Le, B. T., . . . Gilbert, A. L. (2011). Prescriber feedback to improve quality use of medicines among older people: the veterans' MATES program. Journal of pharmacy practice and research, 41(4), 316-319.
DOI Scopus13
2011 Woodward, M. C., Roughead, E. E., Kalisch, L. M., Pratt, N. L., & Le, B. V. T. (2011). Urinary incontinence - are medicines contributing to the problem?. Australasian journal on ageing, 30(1), 28.
DOI
2011 Kalisch Ellett, L. M., Caughey, G. E., Roughead, E. E., & Gilbert, A. L. (2011). The prescribing cascade. Australian prescriber, 34(6), 162-166.
DOI Scopus80 WoS60
2010 Roughead, E., Kalisch, L., Ramsay, E., Ryan, P., & Gilbert, A. (2010). Use of health services and medicines amongst Australian war veterans: a comparison of young elderly, near centenarians and centenarians. BMC Geriatrics, 10(1), 83-90.
DOI Scopus13 WoS9 Europe PMC8
2010 Roughead, E. E., Kalisch Ellett, L. M., Barratt, J. D., & Gilbert, A. L. (2010). Prevalence of potentially hazardous drug interactions amongst Australian veterans. British journal of clinical pharmacology, 70(2), 252-257.
DOI Scopus57 WoS43 Europe PMC38
2010 Kalisch, L. M., Roughead, E. E., & Gilbert, A. L. (2010). Improving heart failure outcomes with pharmacist-physician collaboration: How close are we?. Future Cardiology, 6(2), 255-268.
DOI Scopus10 WoS8 Europe PMC6
2009 Kalisch Ellett, L. M., Roughead, E. E., & Gilbert, A. L. (2009). Pharmaceutical brand substitution in Australia : identifying factors associated with having multiple brand substitutions. International journal of pharmacy practice, 17(6), 339-344.
DOI

Year Citation
2021 Eshetie, T., Kalisch Ellett, L. M., Larson, E. B., Gillam, M. H., Nguyen, T. A., Marcum, Z. A., . . . Gray, S. L. (2021). Potentially inappropriate medication use and adverse health outcomes in people with dementia. Poster session presented at the meeting of Journal Of The American Geriatrics Society. US: Wiley-Blackwell Publishing.
2019 Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. (2019). HOW DO CLINICIANS AND PHARMACISTS ASSESS POLYPHARMACY IN A CASE-BASED SETTING?. Poster session presented at the meeting of RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY. ELSEVIER SCIENCE INC.
2019 Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. (2019). Identifying patients at risk of adverse outcomes from inappropriate polypharmacy. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY.
2015 Caughey, G. E., Kalisch Ellett, L. M., & Barratt, J. D. (2015). Spontaneous adverse event reports associated with apixaban and potentially inappropriate medicine use: an international comparison. Poster session presented at the meeting of Pharmacoepidemiology and Drug Safety. UK: John Wiley & Sons.

Year Citation
2024 Gebreyohannes, E. A., Thornton, C., Thiessen, M., de Vries, S. T., Q Andrade, A., Kalisch Ellett, L., . . . Lim, R. (2024). Co-Designing a Consumer-Focused Digital Reporting Health Platform to Improve Adverse Medicine Event Reporting: Protocol for a Multimethod Research Project (the ReMedi Project) (Preprint).
DOI

  • Large scale evidence generation for the utilisation and safety of biologic medicines, NHMRC - Project Grant, 01/01/2019 - 31/12/2023

  • Citizen Science, Health and Wellbeing Project, Office for Ageing Well, 01/02/2020 - 18/03/2022

  • Veterans' Medicines Advice and Therapeutics Education Services (Veterans' MATES) Program, Cwth Dept of Veterans' Affairs, 01/09/2015 - 31/12/2021

  • Consumer and clinician led priority setting for the NNIDR MEDicines and DEMentia (MEDDEM) National Research Action Plan, Australian Association of Gerontology Research Trust, 01/01/2020 - 21/12/2021

  • Medicine-associated dementia and cognitive impairment: identifying the problem, reducing the harm, NHMRC - ARC Dementia Research Development Fellowship, 01/08/2016 - 30/06/2021

  • CVC Mental Health Pilot, Cwth Dept of Veterans' Affairs, 03/01/2018 - 31/12/2020

Courses I teach

  • PHAR 3021 Quality Use of Medicines (2025)
  • PHAR 3021 Quality Use of Medicines (2024)

Date Role Research Topic Program Degree Type Student Load Student Name
2024 Principal Supervisor - Doctor of Philosophy Doctorate Full Time Ms Jess Coddo
2023 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Miss Deirdre Landsberg
2023 Principal Supervisor - Doctor of Philosophy Doctorate Full Time Mrs Penelope Alvaro
2022 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Miss Lauren Mae Fraser
2022 Principal Supervisor - Doctor of Philosophy Doctorate Full Time Miss Hana Amer

Date Role Membership Country
2024 - ongoing President Australasian Pharmaceutical Science Association -
2023 - ongoing Member Pharmaceutical Society of Australia -

Date Role Editorial Board Name Institution Country
2022 - ongoing Editor British Journal of Clinical Pharmacology British Pharmacological Society United Kingdom

Date Office Name Institution Country
2024 - 2026 President Australasian Pharmaceutical Science Association Australia
2019 - 2023 Secretary Australasian Pharmaceutical Science Association Australia
2018 - 2018 Council Member Australasian Pharmaceutical Science Association Australia

Connect With Me

External Profiles

Other Links